We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Notice for mRNA-1345 (for Respiratory Syncytial Virus (RSV) pre-fusion F protein (Moderna Australia Pty Ltd)
Active ingredients
mRNA-1345 (for Respiratory Syncytial Virus (RSV) pre-fusion F protein
Sponsor
Date of review outcome
Lapse date
Type
Priority review
Indication
Prevention of Respiratory syncytial virus (RSV)-associated lower respiratory tract disease (LRTD), initially in adults ≥ 60 years of age
Therapeutic area
Vaccines